Lupin receives FDA approval for Tadalafil Tablets USP

Company |  News | 0 Comment | 27 Mar, 2019

Pharma major Lupin Limited (Lupin) announced that it has received approval for its Tadalafil Tablets USP, 2.5 mg, 5 mg, 10 mg, and 20 mg, from the United States Food and Drug Administration...Read more

Lupin's Pune Biotech facility receives EU GMP clearance

Company |  News | 0 Comment | 27 Mar, 2019

Pharma major Lupin Limited has announced that it has received the ‘European Good Manufacturing Practice’ (EU GMP) certificate for its Mammalian Facility in Pune where Etanercept...Read more

Novartis plans for Alcon spin-off on April 9, 2019

Company |  News | 0 Comment | 27 Mar, 2019

Novartis confirmed that certain important conditions precedent for the 100% spin-off of the Alcon eye care business have been met, including receipt of certain necessary authorizations and ...Read more

Lupin and YL Biologics receives PMDA approval for Etanercept biosimilar in Japan

Company |  News | 0 Comment | 26 Mar, 2019

Lupin has announced that YL Biologics Limited (YLB), a joint venture between Lupin’s subsidiary Lupin Atlantis Holdings SA (LAHSA) and Yoshindo Inc. in Japan, and Lupin (through its J...Read more

Lupin receives FDA approval for Sildenafil Tablets

Company |  News | 0 Comment | 25 Mar, 2019

Lupin has announced that it has received approval for its Sildenafil Tablets USP, 25 mg, 50 mg, and 100 mg from the United States Food and Drug Administration (FDA) to market a generic vers...Read more

Lupin launches generic Thyroid tablets in The US

Company |  News | 0 Comment | 22 Mar, 2019

Pharma major Lupin Limited (Lupin) announced the launch of Levothyroxine Sodium Tablets USP, having received an approval from the United States Food and Drug Administration (FDA) earlier. ...Read more

J&J joins forces with Monash University to advance novel technology

Company |  News | 0 Comment | 22 Mar, 2019

Janssen Pharmaceutica N.V, one of the Janssen Pharmaceutical Companies of Johnson & Johnson has announced that it has entered into a sponsored research agreement with the Monash Institu...Read more

EC approves Roche’s MabThera for a rare autoimmune disease

Company |  News | 0 Comment | 19 Mar, 2019

Roche announced that the European Commission has approved MabThera® (rituximab) for the treatment of adults with moderate to severe pemphigus vulgaris (PV), a rare condition characteris...Read more

SCHOTT KAISHA's five city roadshow concludes with resounding success

Company |  News | 0 Comment | 19 Mar, 2019

In a first-ever industry initiative, leading pharmaceutical packaging company SCHOTT KAISHA successfully concluded its 5-city roadshow, bringing together industry experts, R&D specialis...Read more

Glenmark receives ANDA approval for Clindamycin and Benzoyl Peroxide Gel, 1%|5%

Company |  News | 0 Comment | 15 Mar, 2019

Glenmark Pharmaceuticals Inc., has been granted final approval by the United States Food & Drug Administration for Clindamycin and Benzoyl Peroxide Gel, 1%|5%, a generic version of Benz...Read more

Roche, Jothydev’s Diabetes Research Centre set up CoE

Company |  News | 0 Comment | 15 Mar, 2019

Roche, a pioneer in innovative diabetes technologies, has signed a Memorandum of Understanding (MOU) with Jothydev’s Diabetes Research Centre to develop a Centre of Excellence to figh...Read more

Zydus gets USFDA approval for hypertension drug

Company |  News | 0 Comment | 13 Mar, 2019

Zydus Cadila has received the final approval from the USFDA to market Atenolol and Chlorthalidone Tablets USP (US RLD – Tenoretic®), 50 mg/25 mg and 100 mg/25 mg. It will be manuf...Read more

Zydus gets final USFDA nod to sell Potassium Chloride capsules

Company |  News | 0 Comment | 13 Mar, 2019

Zydus Cadila is an innovative, global pharmaceutical company, has received the final approval from the USFDA to market Potassium Chloride Extended-Release Capsules USP (US RLD – Micro...Read more

Piramal Critical Care announces launch of Mitigo in the US

Company |  News | 0 Comment | 12 Mar, 2019

Piramal Critical Care, a global leader in anesthesia, pain management, and intrathecal therapy, today announced the launch of MITIGO™ (Morphine Sulfate Injection, USP – Preserva...Read more

FDA grants accelerated approval to Roche’s Tecentriq in combination with Abraxane

Company |  News | 0 Comment | 12 Mar, 2019

Roche has announced that the US Food and Drug Administration (FDA) has granted accelerated approval to Tecentriq® (atezolizumab) plus chemotherapy (Abraxane® [paclitaxel protein-bou...Read more

Lupin receives FDA approval for Atorvastatin Calcium Tablets

Company |  News | 0 Comment | 08 Mar, 2019

Lupin has announced that it has received approval for its Atorvastatin Calcium Tablets USP, 10 mg, 20 mg, 40 mg, and 80 mg, from the United States Food and Drug Administration (FDA) to mark...Read more

Lilly to introduce lower-priced Insulin

Company |  News | 0 Comment | 07 Mar, 2019

Reinforcing our commitment to lower out-of-pocket costs for people who need insulin, Eli Lilly and Company has announced we will introduce a lower-priced version of Humalog® (insul...Read more

Himalaya Drug introduces Koflet-EX for effective cough management

Company |  News | 0 Comment | 06 Mar, 2019

The Himalaya Drug Company, India’s leading homegrown wellness brand, launches “Koflet-EX”—an effective formulation for symptomatic relief from productive cough assoc...Read more